| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.72B | 28.40B | 27.75B | 28.34B | 31.24B | 29.15B |
| Gross Profit | 13.93B | 12.03B | 9.79B | 8.77B | 9.40B | 9.30B |
| EBITDA | 13.01B | 9.81B | 7.17B | 5.65B | 4.75B | 5.55B |
| Net Income | 10.81B | 6.64B | 4.92B | 3.68B | 3.03B | 4.16B |
Balance Sheet | ||||||
| Total Assets | 104.87B | 90.44B | 75.54B | 67.01B | 67.25B | 68.27B |
| Cash, Cash Equivalents and Short-Term Investments | 22.32B | 27.21B | 23.54B | 20.88B | 20.43B | 26.02B |
| Total Debt | 3.87B | 6.05B | 6.05B | 5.96B | 5.36B | 5.50B |
| Total Liabilities | 19.43B | 20.72B | 18.33B | 17.88B | 16.20B | 15.54B |
| Stockholders Equity | 82.75B | 67.86B | 55.91B | 48.10B | 50.32B | 52.24B |
Cash Flow | ||||||
| Free Cash Flow | 10.00B | 9.24B | 6.17B | 6.43B | 2.48B | 4.38B |
| Operating Cash Flow | 10.32B | 10.28B | 7.34B | 7.48B | 5.24B | 4.88B |
| Investing Cash Flow | -3.77B | -6.82B | -1.86B | -1.45B | -6.00B | -14.21B |
| Financing Cash Flow | -5.45B | -3.83B | -1.54B | -3.42B | -3.71B | 5.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$196.06B | 13.56 | 25.44% | ― | 11.37% | 16.74% | |
73 Outperform | HK$100.01B | 17.65 | 13.77% | 1.01% | 13.62% | 80.52% | |
67 Neutral | HK$26.35B | -39.92 | -4.08% | ― | -10.26% | -85.75% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | HK$16.62B | 5.39 | 12.13% | 8.13% | -1.40% | 22.37% | |
53 Neutral | HK$287.08B | 59.14 | 2.02% | ― | -2.92% | -57.12% | |
47 Neutral | HK$6.86B | 13.03 | 6.13% | 4.71% | -7.61% | -90.51% |